Glenmede Trust’s Nomura Holdings NMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$238K Buy
30,146
+13
+0% +$112 ﹤0.01% 1242
2025
Q4
$253K Buy
+30,133
New +$225K ﹤0.01% 1212
2025
Q1
$171K Sell
27,794
-2,376
-8% -$15.1K ﹤0.01% 1224
2024
Q4
$175K Sell
30,170
-91
-0.3% -$517 ﹤0.01% 1252
2024
Q3
$158K Buy
30,261
+2,657
+10% +$15.1K ﹤0.01% 1257
2024
Q2
$160K Sell
27,604
-2,779
-9% -$16.5K ﹤0.01% 1214
2024
Q1
$195K Buy
30,383
+3,860
+15% +$21.4K ﹤0.01% 1189
2023
Q4
$120K Buy
26,523
+10,127
+62% +$41.7K ﹤0.01% 1190
2023
Q3
$65.9K Sell
16,396
-11,299
-41% -$45K ﹤0.01% 1162
2023
Q2
$105K Hold
27,695
﹤0.01% 1158
2023
Q1
$105K Buy
27,695
+3,168
+13% +$12.5K ﹤0.01% 1164
2022
Q4
$92K Buy
24,527
+3,775
+18% +$13K ﹤0.01% 1160
2022
Q3
$68K Sell
20,752
-2,996
-13% -$10.9K ﹤0.01% 1161
2022
Q2
$85K Sell
23,748
-345
-1% -$1.32K ﹤0.01% 1162
2022
Q1
$101K Buy
24,093
+46
+0.2% +$208 ﹤0.01% 1191
2021
Q4
$104K Buy
24,047
+353
+1% +$1.6K ﹤0.01% 1201
2021
Q3
$117K Sell
23,694
-74
-0.3% -$370 ﹤0.01% 1169
2021
Q2
$120K Buy
23,768
+1,852
+8% +$9.96K ﹤0.01% 1165
2021
Q1
$117K Sell
21,916
-168
-0.8% -$992 ﹤0.01% 1094
2020
Q4
$117K Buy
22,084
+1,179
+6% +$5.83K ﹤0.01% 1092
2020
Q3
$95K Sell
20,905
-419
-2% -$2.04K ﹤0.01% 1181
2020
Q2
$94K Buy
21,324
+7,098
+50% +$29.5K ﹤0.01% 1170
2020
Q1
$73K Hold
14,226
﹤0.01% 1549
2019
Q4
$73K Sell
14,226
-1,366
-9% -$6.59K ﹤0.01% 1549
2019
Q3
$66 Sell
15,592
-5,242
-25% -$19.9K ﹤0.01% 1545
2019
Q2
$73 Buy
20,834
+2,278
+12% +$7.96K ﹤0.01% 1520
2019
Q1
$66 Sell
18,556
-128
-0.7% -$501 ﹤0.01% 1557
2018
Q4
$69 Buy
18,684
+1,727
+10% +$7.75K ﹤0.01% 1462
2018
Q3
$81K Buy
16,957
+641
+4% +$3.04K ﹤0.01% 1304
2018
Q2
$78K Sell
16,316
-810
-5% -$4.41K ﹤0.01% 1319
2018
Q1
$98K Hold
17,126
﹤0.01% 1405
2017
Q4
$98K Buy
17,126
+4,424
+35% +$25.6K ﹤0.01% 1405
2017
Q3
$70K Buy
12,702
+75
+0.6% +$430 ﹤0.01% 1521
2017
Q2
$78K Hold
12,627
﹤0.01% 1454
2017
Q1
$78K Sell
12,627
-1,512
-11% -$9.69K ﹤0.01% 1454
2016
Q4
$82K Sell
14,139
-998
-7% -$5.32K ﹤0.01% 1455
2016
Q3
$66K Buy
15,137
+3,218
+27% +$13.9K ﹤0.01% 1516
2016
Q2
$41K Buy
11,919
+2,169
+22% +$9.04K ﹤0.01% 1644
2016
Q1
$42K Sell
9,750
-282,056
-97% -$1.33M ﹤0.01% 1582
2015
Q4
$1.62M Buy
291,806
+92,724
+47% +$565K 0.01% 659
2015
Q3
$1.16M Buy
199,082
+90,894
+84% +$602K 0.01% 705
2015
Q2
$731K Buy
108,188
+45,293
+72% +$295K 0.01% 818
2015
Q1
$368K Buy
62,895
+30,776
+96% +$176K ﹤0.01% 1080
2014
Q4
$181K Buy
+32,119
New +$190K ﹤0.01% 1343

Other funds holding NMR

Glenmede Trust's NMR Position: Q1 2026 in Review

Glenmede Trust increased its Nomura Holdings (NMR) stake by 0.04% in Q1 2026, buying an estimated $112 and bringing the position to 30,146 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #1242.

Glenmede Trust first reported a position in NMR in Q4 2014 and has held it in 44 quarters since. The position peaked at $1.62M in Q4 2015. 271 funds tracked by Wall St. Rank hold NMR as of Q1 2026.

  • Glenmede Trust held 30,146 shares of Nomura Holdings worth $238K as of Q1 2026.
  • Glenmede Trust bought 13 Nomura Holdings shares in Q1 2026, an estimated $112.
  • Nomura Holdings made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #1242 holding.
  • Glenmede Trust first reported a position in Nomura Holdings in Q4 2014 and has held it in 44 quarters since.
  • Glenmede Trust's Nomura Holdings position peaked at $1.62M in Q4 2015.
  • 271 funds tracked by Wall St. Rank held Nomura Holdings as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.